Acid-Suppressive Efficacy of a Reduced Dosage of Rabeprazole: Comparison of 10 Mg Twice Daily Rabeprazole with 20 Mg Twice Daily Rabeprazole, 30 Mg Twice Daily Lansoprazole, and 20 Mg Twice Daily Omeprazole by 24-Hr Intragastric pH-metry

By Shimatani Tomohiko   Inoue Masaki   Kuroiwa Tomoko   Xu Jing   Tazuma Susumu   Horikawa Yoko   Nakamura Masuo  

Digestive Diseases and Sciences, Vol. 50, Iss. 7, 2005-07 ,pp. : 1202-1206

Springer Publishing Company

Access to resources Recommend Favorite

A Multicenter, Randomized, Double-Blind, 8-Week Comparative Trial of Standard Doses of Esomeprazole (40 mg) and Omeprazole (20 mg) for the Treatment of Erosive Esophagitis

By Schmitt Colleen   Lightdale Charles   Hwang Clara   Hamelin Bernard  

Digestive Diseases and Sciences, Vol. 51, Iss. 5, 2006-05 ,pp. : 844-850

Springer Publishing Company

Access to resources Recommend Favorite

Potent Gastric Acid Inhibition Over 24 Hours by 4-Times Daily Dosing of Esomeprazole 20 mg

By  

Digestion, Vol. 91, Iss. 4, 2015-04 ,pp. : 277-285

Karger

Access to resources Recommend Favorite

Symptom-relieving Effect of Esomeprazole 40 mg Daily in Patients with Heartburn

By Johnsson F.   Hatlebakk J. G.   Klintenberg A.-C.   Román J.  

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 4, 2003-01 ,pp. : 347-353

Informa Healthcare

Access to resources Recommend Favorite

Esomeprazole 40 mg Administered Intravenously Has Similar Safety and Efficacy Profiles to the Oral Formulation in Patients with Erosive Esophagitis

By  

Digestion, Vol. 70, Iss. 4, 2005-03 ,pp. : 250-256

Karger

Access to resources Recommend Favorite